EUVIMEDEUVIMED entdecken
Crossref

Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients

Jessica Newman iD, Neha Patel iD, Shikha Patel iD, Taylor Sprague, Felicia Bartlett, Nikhil Rao, Erika Andrade, Vinayak Rohan, Derek DuBay, Michael J Casey, David Taber iD

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Jessica Newman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Tacrolimus, Kidney Transplantation. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Outcomes analyzing conversion from IR‐tacrolimus (IR) to LCP‐tacrolimus (LCP) in obesity are limited. This was a retrospective longitudinal cohort study of patients converted from IR to LCP from June 2019 to October 2020. Primary outcomes were conversion ratios for weight‐based dose at a steady‐state therapeutic level and identification of appropriate dosing weight. Other outcomes included tacrolimus coefficient of variation (CV), time in therapeutic range (TITR), adverse events, infections, donor specific antibodies (DSAs), and acute rejection. A total of 292 patients were included; 156 and 136 patients with a BMI < 30 and BMI ≥ 30 kg/m 2 , respectively. Baseline characteristics were similar, except for pancreas transplant, diabetes, and HLA mismatch. IR to LCP conversion ratio ranged from .73 to .79. Mean LCP dose was similar (.08 vs. .07 mg/kg/day for BMI < 30 and BMI ≥ 30 kg/m 2 , respectively); there was a significant difference in IR and LCP mg/kg dosing at steady state with TBW (.11 mg/kg vs.09 mg/kg and .08 mg/kg vs. .06 mg/kg, respectively). The most appropriate dosing weight was adjusted body weight (AdjBW), consistent across IR and LCP steady‐state doses, and might yield more accurate steady‐state dosing requirements. In multivariable modeling, BMI was a significant predictor of steady state mg/kg dosing at therapeutic goal for total body weight (TBW), but not ideal body weight (IBW) or AdjBW.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusKidney TransplantationHumansImmunosuppressive AgentsRetrospective StudiesLongitudinal StudiesDelayed-Action PreparationsDrug Administration ScheduleObesityTransplant RecipientsGraft Rejection

Stichwörter der Autor:innen

immunosuppressionobesitytacrolimus

Substanzen

TacrolimusImmunosuppressive AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Pharmacy, Ralph H Johnson VAMC, Charleston, South Carolina, USA.

ORCID-Profile: Jessica Newman, Neha Patel, Shikha Patel, David Taber

Zitieren

APA

Newman, J., Patel, N., Patel, S., Sprague, T., Bartlett, F., Rao, N., Andrade, E., Rohan, V., DuBay, D., Casey, M. J., & Taber, D. (2023). Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15149

Vancouver

Newman J, Patel N, Patel S, Sprague T, Bartlett F, Rao N, et al. Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients. Clinical Transplantation. 2023. doi:10.1111/ctr.15149

BibTeX
@article{Newman2023,
  author = {Newman, Jessica and Patel, Neha and Patel, Shikha and Sprague, Taylor and Bartlett, Felicia and Rao, Nikhil and Andrade, Erika and Rohan, Vinayak and DuBay, Derek and Casey, Michael J and Taber, David},
  title = {Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15149}
}
Kostenlos starten →